Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy

Westbom-Fremer S(2014)Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment Mediat Inflamm 2014 170381-452

Backman M(2002)The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer Clin Cancer Res 8 3480-24

Djureinovic D(1998)Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor Blood 92 4778-2502

Patthey A(2004)Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression FASEB J 18 1439-1586

Isaksson-Mettavainio M(2015)Therapeutic strategy for cancer immunotherapy in head and neck cancer Adv Cell Mol Otolaryngol 3 27690-1351

Gulyas M(2005)Dendritic cell dysfunction in cancer: a mechanism for immunosuppression Immunol Cell Biol 83 451-244

Micke P(2007)Immunosuppressive strategies that are mediated by tumor cells Annu Rev Immunol 25 267-196

Hirsch FR(1999)Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck Clin Cancer Res 5 775-3494

McElhinny A(2008)TGF-beta and tumors--an ill-fated alliance Curr Opin Immunol 20 234-1004

Stanforth D(1996)Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells Nat Med 2 1096-541

Westbom-Fremer S(2014)Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment Mediat Inflamm 2014 170381-452

Backman M(2002)The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer Clin Cancer Res 8 3480-24

Djureinovic D(1998)Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor Blood 92 4778-2502

Patthey A(2004)Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression FASEB J 18 1439-1586

Isaksson-Mettavainio M(2015)Therapeutic strategy for cancer immunotherapy in head and neck cancer Adv Cell Mol Otolaryngol 3 27690-1351

Gulyas M(2005)Dendritic cell dysfunction in cancer: a mechanism for immunosuppression Immunol Cell Biol 83 451-244

Micke P(2007)Immunosuppressive strategies that are mediated by tumor cells Annu Rev Immunol 25 267-196

Hirsch FR(1999)Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck Clin Cancer Res 5 775-3494

McElhinny A(2008)TGF-beta and tumors--an ill-fated alliance Curr Opin Immunol 20 234-1004

Stanforth D(1996)Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells Nat Med 2 1096-541